TRATAMIENTO CON CÉLULAS MADRES PARA EL INFARTO DE MIOCARDIO AGUDO

• Sheila A. Fisher,
• Huajun Zhang,
• Carolyn Doree,
• Anthony Mathur,
• Enca Martin-Rendon

Affiliations

Sheila A. Fisher

U1NHS Blood and Transplant, Systematic Review Initiative, Level 2, John Radcliffe Hospital, Headington, Oxford, UK, OX3 9BQ

Huajun Zhang

PLA General Hospital, Institute of Cardiac Surgery, Department of Cardiovascular Surgery, 28 Fuxing Road, Beijing, China, 100853

Carolyn Doree

U1NHS Blood and Transplant, Systematic Review Initiative, Level 2, John Radcliffe Hospital, Headington, Oxford, UK, OX3 9BQ

Anthony Mathur

William Harvey Research Institute, Department of Clinical Pharmacology, Charterhouse Square, London, UK, EC1M 6BQ

Enca Martin-Rendon

NHS Blood and Transplant, Stem Cell Research Department, John Radcliffe Hospital, Headington, Oxford, UK, OX3 9BQ